Beneficial ownership — 13D / 13G
87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| ALLIANCEBERNSTEIN L.P. | LNKB LINKBANCORP, Inc. | 13G/A | 5.3% | Dec 31, 2023 | 2y |
| Timothy P. Sheehy | BAER Bridger Aerospace Group Holdings, Inc. | 13G | 23.13% | Dec 31, 2023 | 2y |
| ALLIANCEBERNSTEIN L.P. | HRI Herc Holdings Inc | 13G/A | 3.7% | Dec 31, 2023 | 2y |
| Fourthstone LLC | EVBN Evans Bancorp Inc | 13G/A | 1.55% | Dec 31, 2023 | 2y |
| Point72 Asset Management, L.P. | COGT Cogent Biosciences, Inc. | 13G/A | 6.1% | Dec 31, 2023 | 2y |
| AWM Investment Company, Inc. | ARBE Arbe Robotics Ltd. | 13G | 9.95% | Dec 31, 2023 | 2y |
| ArrowMark Colorado Holdings LLC | AXGN Axogen, Inc. | 13G/A | 11.97% | Dec 31, 2023 | 2y |
| BAKER BROS. ADVISORS LP | AKRO Akero Therapeutics, Inc. Common Stock | 13G/A | 4.3% | Dec 31, 2023 | 2y |
| GLAZER CAPITAL, LLC | TWOA two | 13G/A | 0.44% | Dec 31, 2023 | 2y |
| PUBLIC INVESTMENT FUND | TTWO Take Two Interactive Software Inc | 13G/A | 6.7% | Dec 31, 2023 | 2y |
| Radcliffe Capital Management, L.P. | CTAQ Carney Technology Acquisition Corp. II Class A Common Stock | 13G/A | 0% | Dec 31, 2023 | 2y |
| Fort Baker Capital Management LP | LOCC Live Oak Crestview Climate Acquisition Corp. | 13G/A | 0% | Dec 31, 2023 | 2y |
| COHEN & STEERS, INC. | INVH Invitation Homes Inc. | 13G/A | 13.45% | Dec 31, 2023 | 2y |
| ALLIANCEBERNSTEIN L.P. | HAYN Haynes International, Inc. | 13G | 6.3% | Dec 31, 2023 | 2y |
| ALLIANCEBERNSTEIN L.P. | ICHR Ichor Holdings, Ltd. | 13G/A | 3.2% | Dec 31, 2023 | 2y |
| Michael Karp | BXSL Blackstone Secured Lending Fund | 13G/A | 8.7% | Dec 31, 2023 | 2y |
| Aristotle Capital Boston, LLC | ASC Ardmore Shipping Corp | 13G/A | 4.9% | Dec 31, 2023 | 2y |
| Galileo (PTC) Ltd | NU Nu Holdings Ltd. | 13G/A | 2.6% | Dec 31, 2023 | 2y |
| ALLIANCEBERNSTEIN L.P. | GBNY Generations Bancorp NY, Inc. | 13G/A | 9.7% | Dec 31, 2023 | 2y |
| AMERICAN CAPITAL MANAGEMENT INC | AVAV AeroVironment Inc | 13G/A | 4.8% | Dec 31, 2023 | 2y |
| Lynrock Lake LP | BCOV Brightcove, Inc. | 13G/A | 9.9% | Dec 31, 2023 | 2y |
| Konstantakopoulos, Konstantinos | SHIP Seanergy Maritime Holdings Corp. | 13G/A | 6.4% | Dec 31, 2023 | 2y |
| Fourthstone LLC | HMNF HMN Financial Inc | 13G | 5.71% | Dec 31, 2023 | 2y |
| NEEDHAM INVESTMENT MANAGEMENT LLC | KVHI Kvh Industries Inc \De\ | 13G/A | 9.8% | Dec 31, 2023 | 2y |
| Fairmount Funds Management LLC | ANNX Annexon, Inc. | 13G/A | 0.4% | Dec 31, 2023 | 2y |
| BAKER BROS. ADVISORS LP | RYTM Rhythm Pharmaceuticals, Inc. | 13G/A | 10.8% | Dec 31, 2023 | 2y |
| 180 Degree Capital Corp. | PAAI Paradium.AI, Inc. | 13G/A | 5.9% | Dec 31, 2023 | 2y |
| Forbion Capital Fund III Cooperatief U.A. | REPL Replimune Group, Inc. | 13G/A | 8.7% | Dec 31, 2023 | 2y |
| Nantahala Capital Management, LLC | ZVRA Zevra Therapeutics, Inc. | 13G | 6.2% | Dec 31, 2023 | 2y |
| Kopernik Global Investors, LLC | IAG Iamgold Corp | 13G/A | 0.21% | Dec 31, 2023 | 2y |
| Visionary Wealth Advisors | CSPI Csp Inc | 13G | 6.21% | Dec 31, 2023 | 2y |
| Empyrean Capital Partners, LP | VTOL Bristow Group Inc. | 13G/A | 3.64% | Dec 31, 2023 | 2y |
| Amundi | WLDN Willdan Group, Inc. | 13G/A | 13.4% | Dec 31, 2023 | 2y |
| Avoro Capital Advisors LLC | PMVP PMV Pharmaceuticals, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| Rosalind Advisors, Inc. | CLRB Cellectar Biosciences, Inc. | 13G/A | 9.9% | Dec 31, 2023 | 2y |
| AMERIPRISE FINANCIAL INC | BRLT Brilliant Earth Group, Inc. | 13G/A | 6.81% | Dec 31, 2023 | 2y |
| Point72 Asset Management, L.P. | CUTR Cutera, Inc. | 13G/A | 1.1% | Dec 31, 2023 | 2y |
| Berkshire Hathaway Inc | ALLY Ally Financial Inc. | 13G/A | 9.6% | Dec 31, 2023 | 2y |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | AQUC Aquaron Acquisition Corp. | 13G | 8.79% | Dec 31, 2023 | 2y |
| AQR CAPITAL MANAGEMENT LLC | ESYN EnerSyn Global Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| Point72 Asset Management, L.P. | PTGX Protagonist Therapeutics, Inc | 13G/A | 4.5% | Dec 31, 2023 | 2y |
| Fairmount Funds Management LLC | NUVL Nuvalent, Inc. | 13G/A | 3.4% | Dec 31, 2023 | 2y |
| First Trust Capital Management L.P. | LATG Chenghe Acquisition I Co. Class A Ordinary Shares | 13G | 7.35% | Dec 31, 2023 | 2y |
| Ayrton Capital LLC | TBLT ToughBuilt Industries, Inc. Common Stock | 13G | 9.9% | Dec 31, 2023 | 2y |
| Brave Warrior Advisors, LLC | OMF OneMain Holdings, Inc. | 13G | 5.35% | Dec 31, 2023 | 2y |
| Nantahala Capital Management, LLC | UNCY Unicycive Therapeutics, Inc. | 13G/A | 9.9% | Dec 31, 2023 | 2y |
| GLAZER CAPITAL, LLC | BCSA Blockchain Coinvestors Acquisition Corp. I Class A Ordinary Shares | 13G/A | 1% | Dec 31, 2023 | 2y |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | MHD Blackrock Muniholdings Fund, Inc. | 13G | 7.66% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | IMCR Immunocore Holdings plc | 13G | 6% | Dec 31, 2023 | 2y |
| Dean DeSantis | CELH Celsius Holdings, Inc. | 13G | 22.5% | Dec 31, 2023 | 2y |